abstract |
The invention relates to a novel pharmaceutical formulation containing (ether)lysolecithin compounds in a liposomal form. Said pharmaceutical formulation is especially suitable for stimulating leucopoiesis, and for treating tumour diseases and protozoan diseases, especially leishmanioses and amoebic diseases, acariasis and diseases caused by arthropods. |